Christopher Schultz, MD
Gastroenterology · Annapolis, MDNPI 1497787402
Payments from drug & device makers
Across 130 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$291
- Pfizer$167
- Gilead$158
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$132
- Ferring Pharmaceuticals Inc.$71
- plus $624 from 22 others
What the payments were for
- Food & beverage$2,46799%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $1,038 |
| Johnson & Johnson | 21 | $291 |
| Pfizer | 9 | $167 |
| Gilead | 3 | $158 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $132 |
| Ferring Pharmaceuticals Inc. | 4 | $71 |
| Biofire Diagnostics, LLC | 1 | $68 |
| Bristol Myers Squibb | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $58 |
| QOL Medical, LLC | 2 | $45 |
| Intercept Pharmaceuticals, Inc. | 3 | $43 |
| Sanofi | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Endo Pharmaceuticals Inc. | 2 | $27 |
| Alfasigma USA, Inc. | 2 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Echosens North America, Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $18 |
| Celltrion USA Inc. | 1 | $15 |
| Boston Scientific | 1 | $14 |
| UCB, Inc. | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Braintree Laboratories, Inc. | 1 | $12 |
| Intra-sana Laboratories | 1 | $7 |
How this compares
$2,481 in reported general payments places this provider in the 45th percentile of 455 gastroenterology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $76,024 |
| Entecavir | 18 | $14,816 |
| Ursodiol | 30 | $11,927 |
| Mesalamine | 19 | $10,856 |
| Pantoprazole Sodium | 259 | $5,128 |
| Colestipol Hcl | 25 | $3,237 |
| Omeprazole | 90 | $1,982 |
| Famotidine | 88 | $1,381 |
| Esomeprazole Magnesium | 12 | $432 |
| Lansoprazole | 12 | $339 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $221 |
| Ondansetron Hcl | 15 | $133 |
| Carvedilol | 13 | $127 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Annapolis
- Michael EpsteinAnnapolis$1.4M
- Raja TaunkAnnapolis$328K
- Mark FlasarAnnapolis$168K
- Kenolisa OnwuemeBaltimore$4.5M
- Paul ThuluvathBaltimore$3.6M
- Apurva ModiRockville$3.3M
- Louis KormanChevy Chase$1.9M
- Marcia CantoBaltimore$1.6M
- Rudrajit RaiColumbia$1.4M
- Natarajan RavendhranCatonsville$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.